Curaizon solves the problem of drug disobedience by spreading our technology through national health services.
INTRODUCTION
We solve concrete problems by helping patients to use their medications properly:
Every day, millions of people do not take their medications with determination and the personal and financial costs generated are shocking. Around the world, non-compliance leads to $ 700 billion in medical costs that can be avoided.
The data we produce is unique and of considerable value to pharmaceutical companies, researchers and the government.
Every time a patient uses our CuraServe technology, our data increases in utility and value.
Curaizon solves the problem of drug disobedience by spreading our technology through the national health services. As part of our solution, we collect complete anonymous data on how and when patients consume drugs.
Cura Tokens is the only way to access our data. Tokens can be exchanged for access to data, which will advance medical research, reduce health care costs and save lives.
The values of CuraToken ™ are based on real solutions to real problems.
What the company does
We aim to improve medication adherence and bring benefits that change the game for patients and healthcare providers by becoming a leading provider of data compliance and solutions around the world.
What is unique about
Solution Companies We work with patients, their families, and health care providers to ensure that patients take their medications through a series of awareness tools, based on predictive modeling and behavioral analysis tools.
Which problems are solved
by our company CuraServe Technology to help patients take their medications as determined by their doctor. In doing so, we help patients live longer and healthier lives. We also reduce health care costs when patients do not take their medications properly.
How do you create value to support your Token Cura
? Our CuraServe ™ technology generates a wealth of unique, real-time data that shows how people are using their most valuable medicines for a variety of groups, including pharmaceutical companies, medical researchers and biotech companies. CuraTokens allows token owners to access data for queries. When our solution is launched to more patients in more countries. The more data we produce, the more Cura tokens become valuable.
Who is your target customer?
Curaizon sells its compliance solution (Cura Serve) to national health services around the world. Our end users are health care patients who take any form of medication. We also work with industry, pharmaceutical and biotechnology academics, as well as other data users through our Cura Data solution.
What is your target geographic market
Curaizon targets countries with national health services. Currently, it covers 1.4 billion people and this number continues to increase.
What is the potential of the market?
The cost of global non-compliance is more than 600 billion euros each year and produces hundreds of thousands of lives prematurely lost. Chronic and long-term compliance is less than 50%.
Curaizon is the only company with a complete health ecosystem that supports patents by reducing non-compliance. Ecosystems, including CuraServe, CuraData and CuraView, help reduce health care costs and advance medical research.
Curaserve
Communicate with patents using non-intrusive reminders.
Allows family members to support patents. Support healthcare providers with a realistic view of patent behavior.
Curaview
Integrated with legacy health care systems.
Make sure all patent data is currently.
Provide real feedback for electronic medical records.
Curadata
Collect unique and valuable data.
Only store demographic and compliance data. Identification of patents held by the health services.
Available via Token Cura
Many unique and valuable data that we have collected via CuraServe and a house in CuraData. Our system combines the data we collect through our actual compliance technology with our own patent data. This data is stored from the chain to the AES 256 cloud that is encrypted in a geographic domain that corresponds to the block chain storing pointers and rules on access and usage that are all part of CuraData.
It can be accessed independently of health services or EMRs using health care providers who benefit from Big Data if they use a more comprehensive and patented approach; one that also focuses on health care expenditures and treatment outcomes. This is made possible through the analysis of Curaizon data and data. By distributing compliance data produced by CuraServe ™, we are able to measure the effectiveness and durability of each patented medicine by each individual. This information can be used to develop optimal treatment regimens and significantly improve patent results while saving tens of billions of dollars in health services.
Researchers, academics and pharmaceutical companies access information in the form of voluminous data in a completely anonymous form. CuraData's unique architecture enables fast and unparalleled access while ensuring the anonymity of user data via blockchain technology combined with AES 256 encryption and cloud services. This provides increased transparency and reliability in the cloud. exchange of medical data at all levels, from devices to healthcare providers, to unprecedented opportunities to anonymously share Big Data. This protocol allows the relationship between patents, healthcare providers and medical researchers anywhere in the world, regardless of the system used.
ADVANTAGE CURA TOKEN
Token Utility Token Cura (CTKN) allows token holders to access our exclusive and anonymous medical data on the blockchain.
Cura Tokens is the only way to access Curaizon technology.
Holders of Cura Token can access data that uses robust analytics, forecasts, data analysis and massive data to combat drug non-compliance.
Cura Tokens provides real-time analysis of the patient's behavior and compliance.
Cura Tokens enables the use of blockchain technology to manage authentication, privacy and accountability by enabling individuals to control their data, provide protection, security and compliance to all necessary regulations, including GDPR.
Cura Tokens facilitates partnerships with medical and pharmaceutical organizations through the token reward system.
Token Cura owners know they are saving lives around the world by helping to solve the problem of non-compliance.
Social advantages
from Beter Life
Curaizon's main goal is to save lives while reducing costs and improving patent results.
Our CuraServe Soluton will deliver direct and measurable improvements in patent life. Encouraging
higher level of adherence, we reduce episodes of acute illness, hospitalization and more serious complications
such as disability and death. In doing so, we help reduce readmissions to hospital by up to 50% and reduce
overall costs and reduce the financial burden for health care providers. Keeping patents and a healthy family is at the heart of why we do what we do.
Beter Research
The market health analysis is expected to reach $ 24.55 billion in 2021 versus $ 7.39 billion in 2016, an annual growth rate of 27.1%. The next generation of bulky data and analytical tools, but the research data is more daring. CuraData is at the forefront of this paradigm and, thanks to our democrataton data, we can offer benefits to all stakeholders. From patents to health care providers, to analysts to token holders, the main goal is to increase social outcomes.
Our data solutions will support better prescribing guidelines, accelerate drug development, enable physicians to respond quickly, help develop better treatments for chronic and long-term illnesses, identify best practices and make them effective. based on actual results.
Beter
Curaizon Health Care can reduce waste and keep patents healthy and out of hospitals. We do this by involving them as stakeholders in their own care. Technology playing a greater role in health care, patent results, quality of care, efficiency and life expectancy will increase. Every time we help patents take their medications, we reduce the overall cost of healthcare and allow patents to live happier and healthier lives. Curaizon will be the driving force of this mission.
Stored money
Reducing waste and reducing health care costs are very important for countries around the world. Reducing the pressure on payers and allowing these valuable resources to be placed in the most needed places is a very effective way of serving the community.
ICO
General information Details
Token: CTKN
Platform: Ethereum
Standard: ERC20
Quantity: 500,000,000 CTKN
Price: 1 CTKN = 0.20 USD
Payment: ETH
Rigid cap: $ 25,000,000
Pre ICO
Start: 06/01/2018
Completion: 06/08/2018
ICO
Start: 06/08/2018
Regulation: 9/8/2018
January 2016 The development of Cura begins
June 2017 Cura Service Testing takes place
Press release of February 2018 Full Alpha Cura Data
June 1st 2018 Departure Token Presale
June 8, 2018 Start of public token sales
November 2018 Complete the release of data on Cura Beta
March 2019 CuraServe Public Broadcast
July 2019 Growth of the Cura data platform
2020 Cure Data 2.0
TEAM
Chris Matey
Chief Operating Officer
Nicholas James Rumble
Chief Executive Officer (CEO)
Mark Nathan
Financial Director (CFO)
Darran Trute
Chief Technology Officer (CTO)
Luke Lerdal
Chief Data Officer (CDO)
Andrey Verbitsky
Tokenomics Expert
Pencho Gavazov
Director of Business Development
Creative Director Kristaps Kuhalskis
ADVISOR
Dr. Rory McCrea
MB BS, MSc, MRCGP
Sarah Chilvers
BSc, RGN, RHV, MBA, DProf
Links
The main links and contacts of the project are here:
WEB SITE https://curatoken.curaizon.com/
WHITEPAPER https://curatoken.curaizon.com/wp-content/themes/curatoken/White_paper.pdf
LITEPAPPER https://curatoken.curaizon.com/wp-content/themes/curatoken/Lite_paper.pdf
TELEGRAM https://t.me/joinchat/ILiK_Q7VBLOByz_7mMUgsQ
TWITTER https://twitter.com/curaizon
FACEBOOK https://www.facebook.com/curaizonltd/
LINKEDIN https://www.linkedin.com/company/curaizon-ltd/
Author: thegaye
Profile link: https://bitcointalk.org/index.php?action=profile;u=1305050
My ETH: 0x820410Ee0a97e9132aDDBb77c3f35bb3e5115d1e
Komentar
Posting Komentar